Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07167225 · ClinicalTrials.gov registry record
Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
A clinical trial of Cigarette Smoking-Related Carcinoma and E-Cig Use, sponsored by Roswell Park Cancer Institute.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07167225 is a study of Cigarette Smoking-Related Carcinoma and E-Cig Use that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 150 participants, below the 460-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07167225, a study of Cigarette Smoking-Related Carcinoma and E-Cig Use, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.
Conditions Studied
Interventions
- OTHER Effectiveness of different recruitment approaches
- OTHER Choice of study completion locations
- OTHER Cannabis Engagement Assessment
- OTHER E-cigarette dependence Scale
Study Locations (1)
New York
- Roswell Park Comprehensive Cancer Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-04-03 |
| Est. Completion | 2028-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07167225
The ClinicalTrials.gov registry entry for NCT07167225 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 460-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (67% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Effectiveness of different recruitment approaches is the first listed.
NCT07167225 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07167225 about?
NCT07167225 is a clinical study titled "Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)". This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.
What is the current status of trial NCT07167225?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-04-03. Estimated completion is 2028-09-01.
What conditions does trial NCT07167225 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma, E-Cig Use.
What interventions are being tested in trial NCT07167225?
The interventions under investigation include: Effectiveness of different recruitment approaches (OTHER), Choice of study completion locations (OTHER), Cannabis Engagement Assessment (OTHER), E-cigarette dependence Scale (OTHER).
Who is sponsoring clinical trial NCT07167225?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07167225 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
RECRUITING · Early Phase 1
-
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
RECRUITING · Phase 4
-
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
RECRUITING · Phase 2
-
CONNECTing to LungCare
RECRUITING · NA
-
Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.